Curaleaf Holdings (CURLF) Revenue (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Revenue of $324.2 million for Q1 2026, up 5.74% year-over-year from $306.6 million in Q1 2025, and little changed quarter-over-quarter from $323.4 million in Q4 2025.
Curaleaf Holdings (CURLF) Revenue (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Revenue history runs 8 years deep, the most recent figure standing at $324.2 million for Q1 2026.
- In Q1 2026, Revenue rose 5.74% year-over-year to $324.2 million; the TTM figure through Mar 2026 stood at $1.3 billion (down 1.51% YoY), while the FY2025 annual figure was $1.3 billion, down 4.96% from the prior year.
- Revenue for Q1 2026 stood at $324.2 million, roughly flat from $323.4 million in the prior quarter.
- The five-year high for Revenue was $351.3 million in Q4 2022, with the low at $345269.0 in Q4 2023.
- The 5-year median for Revenue is $324.6 million (2022), against an average of $306.3 million.
- The sharpest annual moves came in 2023 and 2024: Revenue slumped 99.9% in 2023, then surged 93320.2% in 2024.
- Curaleaf Holdings' Revenue stood at $351.3 million in 2022, then plunged by 99.9% to $345269.0 in 2023, then soared by 93320.2% to $322.6 million in 2024, then grew by 0.25% to $323.4 million in 2025, then grew by 0.27% to $324.2 million in 2026.
- Business Quant data shows CURLF's Revenue at $324.2 million in Q1 2026, $323.4 million in Q4 2025, and $320.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Curaleaf Holdings | 2.55 Bn | 2.45 Bn | 169.91 Mn | 340.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 340.10 Mn |
| Mar 31, 2026 | 324.23 Mn |
| Dec 31, 2025 | 323.36 Mn |
| Sep 30, 2025 | 320.24 Mn |
| Jun 30, 2025 | 314.52 Mn |
| Mar 31, 2025 | 306.62 Mn |
| Dec 31, 2024 | 322.55 Mn |
| Sep 30, 2024 | 330.53 Mn |
| Jun 30, 2024 | 342.29 Mn |
| Mar 31, 2024 | 338.93 Mn |
| Dec 31, 2023 | 345,269.00 |
| Sep 30, 2023 | 333.17 Mn |
| Jun 30, 2023 | 335.55 Mn |
| Dec 31, 2022 | 351.31 Mn |
| Sep 30, 2022 | 324.64 Mn |
| Jun 30, 2022 | 325.75 Mn |
| Dec 31, 2021 | 308.05 Mn |
| Sep 30, 2021 | 316.58 Mn |
| Jun 30, 2021 | 310.58 Mn |
| Dec 31, 2020 | 229.28 Mn |